Chronic Spontaneous Urticaria: The Importance of Prompt Diagnosis and Evidence-Based Management with Targeted Biologic Therapies
DATE | TIME | REGISTRATION LINK |
---|---|---|
Monday, March 18, 2024 | 7:00 PM – 8:30 PM EST | REGISTER NOW |
Thursday, March 28, 2024 | 7:00 PM – 8:30 PM EST | REGISTER NOW |
Thursday, April 4, 2024 | 7:00 PM – 8:30 PM EST | REGISTER NOW |
PROGRAM FEATURES
- Online personalized quality-improvement poster-generation portal
- Downloadable animations
FACULTY
David Lang, MD Professor of Medicine, Cleveland Clinic Lerner College of Medicine Department of Allergy and Clinical Immunology Cleveland Clinic Cleveland, OH |
|
Gil Yosipovitch, MD Professor, Stiefel Chair of Medical Dermatology Director Miami Itch Center Dr Phillip Frost Department of Dermatology and Cutaneous Surgery Miller School of Medicine University of Miami Miami, FL |
PROGRAM OVERVIEW
Dermatologists are insufficiently familiar with the clinical phenotypical presentations and symptoms and disease characteristics of CSU, which leads to ongoing delays in diagnosis, poor prognosis, and negatively impacts on patient’s quality of life. Uncontrolled cases of CSU continue to persist despite treatment with antihistamines and oral corticosteroids; and strategies for selecting and sequencing treatment per evidence-based guidelines and patient specific factors, are suboptimal—leading to less favorable patient outcomes.
TARGET AUDIENCE
This program will meet the educational needs of dermatologists who diagnose, treat, and/or manage patients with CSU.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Facilitate prompt CSU diagnosis through identification of the clinical symptoms and associated biomarker testing
- Review the most recent clinical evidence for emerging and investigational biologic therapies in the treatment of CSU
- Understand evidence-based strategies for treatment selection considering clinical guidelines and patient-specific factors
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]